| A1 | BCL2A1—BCL2-related protein A1 |
| A20 | TNFAIP3 —Tumour necrosis factor α-induced protein 3 |
| ABIN-1 | A20 binding inhibitor of NF-κB |
| ADAP | Adhesion- and degranulation-promoting adaptor protein |
| ALCL | Anaplastic large-cell lymphoma |
| ALL | Acute lymphoblastic leukaemia |
| AML | Acute myeloid leukaemia |
| ARD | Ankyrin repeat domain |
| ATM | Ataxia telangiectasia mutated |
| BAD | Bcl-2-associated death promoter |
| BAFF | B-cell activating factor |
| BAK | BCL-2 antagonist/killer |
| BAX | BCL-2-associated X protein |
| BCL10 | B-cell CLL/lymphoma 10 |
| BCL-2 | B-cell lymphoma 2 |
| Bcl-XL | B-cell lymphoma-extra large |
| BCR | B-cell receptor |
| BH | BCL-2 homology |
| BID | BH3 interacting-domain death agonist |
| BIM | BCL-2-interacting mediator of cell death |
| BIR | Baculovirus IAP repeat |
| CAML | Calcium modulating ligand |
| CARD | Caspase recruitment domain |
| CBM | CARD11-BCL10-MALT1 |
| CD40L | CD40 ligand |
| Cdc25A | Cell division cycle 25A |
| c-FLIP | Cellular FLICE/caspase8-like inhibitory protein |
| c-IAP | Cellular inhibitor of apoptosis |
| CLL | Chronic lymphocytic leukaemia |
| CYLD | Cylindromatosis lysine 63 deubiquitinase |
| DAMP | Damage-associated molecular patterns |
| DHMEQ | Dehydroxymethylepoxyquinomicin |
| DLBCL | Diffuse large B-cell lymphoma |
| DMAPT | Dimethylaminoparthenolide |
| DUB | Deubiquitination enzyme |
| Emi1-FBXO 5 | F-box protein 5 |
| EMT | Epithelial-mesenchymal transition |
| FBXW | F-box and WD repeat domain containing |
| FDA | US Food and Drug Administration |
| FL | Follicular lymphoma |
| GADD45β | Growth arrest and DNA damage inducible β |
| GBM | Glioblastoma multiforme |
| GRR | Glycine rich region |
| GSK3 | Glycogen synthase kinase 3 |
| HAT | Histone acetyltransferase |
| HDAC | Histone deacetylases |
| HL | Hodgkin’s lymphoma |
| HOIL-1L | RBCK1—RanBP-type and C3HC4-type zinc finger containing 1 |
| HOIP | RNF31—Ring finger protein 31 |
| IKK | IκB kinase |
| IL-1β | Interleukin 1 β |
| IL-1β | Interleukin 1β |
| IL-1βR | IL-1β receptor |
| IRAK | Interleukin-1 receptor-associated kinase |
| IκB | Nuclear factor of κ light polypeptide gene enhancer in B-cells inhibitor |
| JAK | Janus kinase |
| LPS | Lipopolysaccharide |
| LTβ | Lymphotoxin β |
| LUBAC | Linear ubiquitination assembly complex |
| MALT | Mucosa-associated lymphoid tissue |
| MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 |
| MAP | Mitogen activated protein |
| MAPKKK | Mitogen activated protein kinase kinase kinase |
| MAVS | Mitochondrial antiviral signalling protein |
| MCL | Mantle-cell lymphoma |
| MCL1 | Myeloid cell leukaemia sequence 1 |
| MDS | Myelodysplastic syndrome |
| MEKK | Mitogen activated protein kinase kinase |
| MM | Multiple myeloma |
| mTOR | Mechanistic target of rapamycin |
| MYD88 | Myeloid differentiation primary response protein 88 |
| NEDD8 | Neural precursor cell-expressed developmentally down-regulated 8 |
| NES | Nuclear export signal |
| NF-κB | Nuclear factor κ B (Nuclear Factor binding to the κ-Light-chain-enhancer B site) |
| NHL | Non-Hodgkin’s lymphoma |
| NIK | NF-κB-inducing kinase |
| NLR | NOD-like receptor |
| NLS | Nuclear localization signals |
| NOD | Nucleotide-binding oligomerisation domain |
| NSCLC | Non-Small Cell Lung Cancer |
| OTUD7B | OTU domain-containing protein 7B |
| PAMP | Pathogen-associated molecular pattern |
| PAR | Poly(ADP-ribose) |
| PARP-1 | Poly(ADP-ribose)-polymerase-1 |
| PDK | Phosphoinoisitide-dependent kinase |
| PDK1 | 3-Phosphoinositide-dependent protein kinase 1 |
| PDLIM2 | PDZ and LIM domain protein 2 |
| PIASy | Protein inhibitor of activated STAT protein y |
| PIDD | p53-induced death domain protein |
| PKC | Protein kinase C |
| PP | Protein phosphatase |
| PTEN | Phosphatase and tensin homolog |
| PUMA | p53 upregulated modulator of apoptosis |
| RANKL | Receptor activator of NF-κB ligand |
| RAS | Rat sarcoma virus oncogene |
| RBX1 | RING-box protein 1 |
| RHD | Rel-homology Domain |
| RIP | Receptor interacting protein |
| RLH | RNA helicase |
| RLR | RIG-I-like receptor |
| SCF | SKP1-Cullin 1-F-box protein |
| Sharpin | SHANK-associated RH domain interacting protein |
| SL | Sesquiterpene lactone |
| SMAC | Second mitochondria-derived activator of caspases |
| SOCS-1 | Suppressor of cytokine signalling-1 |
| STAT | Signal transducer and activator of transcription |
| SUMO | Small ubiquitin-like modifiers |
| TAB | TAK1-associated binding protein |
| TACI | TNFRSF13B—TNF receptor superfamily member 13B |
| TAK1 | Transforming growth factor β-activated kinase 1 |
| T-ALL | T-cell acute lymphoblastic leukaemia |
| TBK1 | TANK-binding kinase |
| TCR | T-cell receptor |
| TLR | Toll-like receptor |
| TME | Tumour microenvironment |
| TNF-R | TNF receptor |
| TNFSF | Tumour necrosis factor superfamily member |
| TNF-α | Tumour necrosis factor-α |
| TRADD | TNF receptor-associated death domain protein |
| TRAF | TNF receptor-associated factor |
| TRIM23 | Tripartite motif protein 23 |
| TWEAK | TNF-related weak inducer of apoptosis |
| UBA | Ubiquitin-activating enzyme, E1 |
| UBC | Ubiquitin-conjugating, E2 |
| Ubc/Uev | Ubiquitin-conjugating enzyme/ubiquitin E2 variant |
| UBD | Ubiquitin-binding domain |
| UPP | Ubiquitin-proteasome pathway |
| UPR | Unfolded protein response |
| USP | Ubiquitin-specific peptidase |
| WIP1 | Wild-type p53-induced phosphatase 1 |
| WM | Waldenström’s macroglobulinemia |
| WWOX | WW domain-containing oxidoreductase |
| βTrCP | β-transducin repeat-containing protein |